nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.579	1	CiPCiCtD
Voriconazole—CYP3A5—Beclomethasone—psoriasis	0.0293	0.115	CbGbCtD
Voriconazole—CYP2B6—Cholecalciferol—psoriasis	0.0171	0.0668	CbGbCtD
Voriconazole—CYP3A7—Hydrocortisone—psoriasis	0.0125	0.0488	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0125	0.0488	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0118	0.0461	CbGbCtD
Voriconazole—CYP3A7—Cyclosporine—psoriasis	0.0118	0.0461	CbGbCtD
Voriconazole—CYP3A5—Mycophenolate mofetil—psoriasis	0.0116	0.0456	CbGbCtD
Voriconazole—FMO3—sweat—psoriasis	0.011	0.848	CbGeAlD
Voriconazole—CYP2C19—Cholecalciferol—psoriasis	0.0108	0.0424	CbGbCtD
Voriconazole—CYP3A4—Calcitriol—psoriasis	0.0102	0.0398	CbGbCtD
Voriconazole—CYP3A5—Hydrocortisone—psoriasis	0.00935	0.0366	CbGbCtD
Voriconazole—CYP2C9—Cholecalciferol—psoriasis	0.00901	0.0353	CbGbCtD
Voriconazole—CYP3A5—Cyclosporine—psoriasis	0.00883	0.0346	CbGbCtD
Voriconazole—CYP3A4—Methoxsalen—psoriasis	0.00791	0.031	CbGbCtD
Voriconazole—CYP3A7—Dexamethasone—psoriasis	0.00775	0.0303	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00775	0.0303	CbGbCtD
Voriconazole—CYP2C19—Prednisone—psoriasis	0.00751	0.0294	CbGbCtD
Voriconazole—CYP2B6—Dexamethasone—psoriasis	0.00738	0.0289	CbGbCtD
Voriconazole—CYP2C19—Cyclosporine—psoriasis	0.00712	0.0279	CbGbCtD
Voriconazole—CYP2C9—Cyclosporine—psoriasis	0.00592	0.0232	CbGbCtD
Voriconazole—CYP3A5—Dexamethasone—psoriasis	0.00581	0.0228	CbGbCtD
Voriconazole—CYP3A4—Cholecalciferol—psoriasis	0.00524	0.0205	CbGbCtD
Voriconazole—CYP2C19—Dexamethasone—psoriasis	0.00469	0.0184	CbGbCtD
Voriconazole—CYP3A4—Triamcinolone—psoriasis	0.00454	0.0178	CbGbCtD
Voriconazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.00454	0.0178	CbGbCtD
Voriconazole—CYP2C9—Dexamethasone—psoriasis	0.0039	0.0153	CbGbCtD
Voriconazole—CYP3A4—Betamethasone—psoriasis	0.0039	0.0153	CbGbCtD
Voriconazole—CYP3A4—Prednisolone—psoriasis	0.00385	0.0151	CbGbCtD
Voriconazole—CYP3A4—Hydrocortisone—psoriasis	0.00365	0.0143	CbGbCtD
Voriconazole—CYP3A4—Prednisone—psoriasis	0.00363	0.0142	CbGbCtD
Voriconazole—CYP3A4—Cyclosporine—psoriasis	0.00344	0.0135	CbGbCtD
Voriconazole—CYP3A4—Dexamethasone—psoriasis	0.00227	0.00888	CbGbCtD
Voriconazole—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.000803	0.0561	CbGpPWpGaD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000783	0.0547	CbGpPWpGaD
Voriconazole—FMO1—tendon—psoriasis	0.000694	0.0533	CbGeAlD
Voriconazole—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.000673	0.047	CbGpPWpGaD
Voriconazole—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000607	0.0424	CbGpPWpGaD
Voriconazole—PTGS1—endothelium—psoriasis	0.000577	0.0444	CbGeAlD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00056	0.0391	CbGpPWpGaD
Voriconazole—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000553	0.0386	CbGpPWpGaD
Voriconazole—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000498	0.0347	CbGpPWpGaD
Voriconazole—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000486	0.034	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—CYP2S1—psoriasis	0.000416	0.029	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—CYP2S1—psoriasis	0.00041	0.0286	CbGpPWpGaD
Voriconazole—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000376	0.0263	CbGpPWpGaD
Voriconazole—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000343	0.0239	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—CYP2S1—psoriasis	0.000297	0.0208	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—CYP2S1—psoriasis	0.000293	0.0205	CbGpPWpGaD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000279	0.0195	CbGpPWpGaD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000276	0.0193	CbGpPWpGaD
Voriconazole—CYP2B6—skin of body—psoriasis	0.000273	0.021	CbGeAlD
Voriconazole—PTGS1—skin of body—psoriasis	0.000246	0.0189	CbGeAlD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000227	0.0158	CbGpPWpGaD
Voriconazole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000226	0.0158	CbGpPWpGaD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00022	0.0153	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000207	0.0144	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000204	0.0142	CbGpPWpGaD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000202	0.0141	CbGpPWpGaD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000199	0.0139	CbGpPWpGaD
Voriconazole—PTGS1—tendon—psoriasis	0.000188	0.0144	CbGeAlD
Voriconazole—FMO3—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000185	0.0129	CbGpPWpGaD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000168	0.0117	CbGpPWpGaD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000164	0.0114	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000162	0.0113	CbGpPWpGaD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000156	0.0109	CbGpPWpGaD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000154	0.0108	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL13—psoriasis	0.000146	0.0102	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000142	0.00994	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000141	0.00981	CbGpPWpGaD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000127	0.00884	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.00012	0.0084	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000119	0.00829	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000117	0.00814	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000115	0.00806	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.000105	0.00736	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.49e-05	0.00663	CbGpPWpGaD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.39e-05	0.00656	CbGpPWpGaD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.27e-05	0.00647	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL10—psoriasis	9.12e-05	0.00637	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP2S1—psoriasis	8.9e-05	0.00621	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	8.78e-05	0.00613	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—CYP2S1—psoriasis	8.7e-05	0.00607	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	8.58e-05	0.00599	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—NDUFA5—psoriasis	8.36e-05	0.00584	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.61e-05	0.00532	CbGpPWpGaD
Voriconazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	7.51e-05	0.00524	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	7.34e-05	0.00512	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP2S1—psoriasis	7.11e-05	0.00497	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—CYP2S1—psoriasis	6.72e-05	0.0047	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	6.63e-05	0.00463	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.62e-05	0.00462	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.54e-05	0.00457	CbGpPWpGaD
Voriconazole—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	6.52e-05	0.00455	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—CYP2S1—psoriasis	6.13e-05	0.00428	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	6.05e-05	0.00422	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	5.99e-05	0.00418	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—NDUFA5—psoriasis	5.98e-05	0.00417	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	5.92e-05	0.00413	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP2S1—psoriasis	5.08e-05	0.00355	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.98e-05	0.00348	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	4.75e-05	0.00332	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—JUN—psoriasis	4.63e-05	0.00324	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.56e-05	0.00318	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.46e-05	0.00311	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	4.37e-05	0.00305	CbGpPWpGaD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.31e-05	0.00301	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.05e-05	0.00283	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.04e-05	0.00282	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.99e-05	0.00278	CbGpPWpGaD
Voriconazole—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	3.88e-05	0.00271	CbGpPWpGaD
Voriconazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.49e-05	0.00244	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CARM1—psoriasis	3.47e-05	0.00242	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—TNF—psoriasis	3.47e-05	0.00242	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	3.33e-05	0.00232	CbGpPWpGaD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.01e-05	0.0021	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL6—psoriasis	2.8e-05	0.00196	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	2.77e-05	0.00193	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CARM1—psoriasis	2.48e-05	0.00173	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NDUFA5—psoriasis	2.42e-05	0.00169	CbGpPWpGaD
Voriconazole—Anxiety—Betamethasone—psoriasis	2.41e-05	0.000174	CcSEcCtD
Voriconazole—Vomiting—Mycophenolic acid—psoriasis	2.4e-05	0.000173	CcSEcCtD
Voriconazole—Discomfort—Betamethasone—psoriasis	2.39e-05	0.000173	CcSEcCtD
Voriconazole—Discomfort—Dexamethasone—psoriasis	2.39e-05	0.000173	CcSEcCtD
Voriconazole—Dyspepsia—Hydrocortisone—psoriasis	2.39e-05	0.000173	CcSEcCtD
Voriconazole—Rash—Mycophenolic acid—psoriasis	2.38e-05	0.000172	CcSEcCtD
Voriconazole—Dermatitis—Mycophenolic acid—psoriasis	2.38e-05	0.000172	CcSEcCtD
Voriconazole—Pain—Prednisolone—psoriasis	2.38e-05	0.000172	CcSEcCtD
Voriconazole—Hepatitis—Methotrexate—psoriasis	2.38e-05	0.000172	CcSEcCtD
Voriconazole—Urticaria—Mycophenolate mofetil—psoriasis	2.37e-05	0.000171	CcSEcCtD
Voriconazole—Headache—Mycophenolic acid—psoriasis	2.37e-05	0.000171	CcSEcCtD
Voriconazole—Decreased appetite—Hydrocortisone—psoriasis	2.36e-05	0.00017	CcSEcCtD
Voriconazole—Pharyngitis—Methotrexate—psoriasis	2.36e-05	0.00017	CcSEcCtD
Voriconazole—Abdominal pain—Mycophenolate mofetil—psoriasis	2.36e-05	0.00017	CcSEcCtD
Voriconazole—Body temperature increased—Mycophenolate mofetil—psoriasis	2.36e-05	0.00017	CcSEcCtD
Voriconazole—Urinary tract disorder—Methotrexate—psoriasis	2.35e-05	0.000169	CcSEcCtD
Voriconazole—PTGS1—Metabolism—NDUFA5—psoriasis	2.35e-05	0.00164	CbGpPWpGaD
Voriconazole—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.34e-05	0.000169	CcSEcCtD
Voriconazole—Vision blurred—Prednisone—psoriasis	2.33e-05	0.000168	CcSEcCtD
Voriconazole—Urethral disorder—Methotrexate—psoriasis	2.33e-05	0.000168	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Triamcinolone—psoriasis	2.33e-05	0.000168	CcSEcCtD
Voriconazole—Pain—Hydrocortisone—psoriasis	2.32e-05	0.000168	CcSEcCtD
Voriconazole—Anaphylactic shock—Dexamethasone—psoriasis	2.32e-05	0.000168	CcSEcCtD
Voriconazole—Anaphylactic shock—Betamethasone—psoriasis	2.32e-05	0.000168	CcSEcCtD
Voriconazole—Oedema—Betamethasone—psoriasis	2.32e-05	0.000168	CcSEcCtD
Voriconazole—Oedema—Dexamethasone—psoriasis	2.32e-05	0.000168	CcSEcCtD
Voriconazole—Insomnia—Triamcinolone—psoriasis	2.31e-05	0.000167	CcSEcCtD
Voriconazole—Infection—Dexamethasone—psoriasis	2.3e-05	0.000166	CcSEcCtD
Voriconazole—Infection—Betamethasone—psoriasis	2.3e-05	0.000166	CcSEcCtD
Voriconazole—Ill-defined disorder—Prednisone—psoriasis	2.3e-05	0.000166	CcSEcCtD
Voriconazole—Paraesthesia—Triamcinolone—psoriasis	2.3e-05	0.000166	CcSEcCtD
Voriconazole—Feeling abnormal—Prednisolone—psoriasis	2.29e-05	0.000165	CcSEcCtD
Voriconazole—Visual impairment—Methotrexate—psoriasis	2.29e-05	0.000165	CcSEcCtD
Voriconazole—Anaemia—Prednisone—psoriasis	2.29e-05	0.000165	CcSEcCtD
Voriconazole—Shock—Dexamethasone—psoriasis	2.28e-05	0.000165	CcSEcCtD
Voriconazole—Shock—Betamethasone—psoriasis	2.28e-05	0.000165	CcSEcCtD
Voriconazole—Dyspnoea—Triamcinolone—psoriasis	2.28e-05	0.000165	CcSEcCtD
Voriconazole—Nervous system disorder—Betamethasone—psoriasis	2.27e-05	0.000164	CcSEcCtD
Voriconazole—Nervous system disorder—Dexamethasone—psoriasis	2.27e-05	0.000164	CcSEcCtD
Voriconazole—Agitation—Prednisone—psoriasis	2.27e-05	0.000164	CcSEcCtD
Voriconazole—Thrombocytopenia—Betamethasone—psoriasis	2.27e-05	0.000164	CcSEcCtD
Voriconazole—Thrombocytopenia—Dexamethasone—psoriasis	2.27e-05	0.000164	CcSEcCtD
Voriconazole—Tachycardia—Dexamethasone—psoriasis	2.26e-05	0.000163	CcSEcCtD
Voriconazole—Tachycardia—Betamethasone—psoriasis	2.26e-05	0.000163	CcSEcCtD
Voriconazole—Angioedema—Prednisone—psoriasis	2.26e-05	0.000163	CcSEcCtD
Voriconazole—Hypersensitivity—Cyclosporine—psoriasis	2.25e-05	0.000163	CcSEcCtD
Voriconazole—Dyspepsia—Triamcinolone—psoriasis	2.25e-05	0.000163	CcSEcCtD
Voriconazole—Erythema multiforme—Methotrexate—psoriasis	2.25e-05	0.000162	CcSEcCtD
Voriconazole—Nausea—Mycophenolic acid—psoriasis	2.24e-05	0.000162	CcSEcCtD
Voriconazole—Hyperhidrosis—Betamethasone—psoriasis	2.24e-05	0.000162	CcSEcCtD
Voriconazole—Hyperhidrosis—Dexamethasone—psoriasis	2.24e-05	0.000162	CcSEcCtD
Voriconazole—Feeling abnormal—Hydrocortisone—psoriasis	2.24e-05	0.000162	CcSEcCtD
Voriconazole—Malaise—Prednisone—psoriasis	2.23e-05	0.000161	CcSEcCtD
Voriconazole—Vertigo—Prednisone—psoriasis	2.22e-05	0.000161	CcSEcCtD
Voriconazole—Eye disorder—Methotrexate—psoriasis	2.22e-05	0.00016	CcSEcCtD
Voriconazole—Gastrointestinal pain—Hydrocortisone—psoriasis	2.22e-05	0.00016	CcSEcCtD
Voriconazole—Syncope—Prednisone—psoriasis	2.22e-05	0.00016	CcSEcCtD
Voriconazole—Tinnitus—Methotrexate—psoriasis	2.22e-05	0.00016	CcSEcCtD
Voriconazole—Anorexia—Betamethasone—psoriasis	2.21e-05	0.00016	CcSEcCtD
Voriconazole—Anorexia—Dexamethasone—psoriasis	2.21e-05	0.00016	CcSEcCtD
Voriconazole—Urticaria—Prednisolone—psoriasis	2.21e-05	0.000159	CcSEcCtD
Voriconazole—Cardiac disorder—Methotrexate—psoriasis	2.2e-05	0.000159	CcSEcCtD
Voriconazole—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.2e-05	0.000159	CcSEcCtD
Voriconazole—Asthenia—Cyclosporine—psoriasis	2.19e-05	0.000158	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.19e-05	0.00153	CbGpPWpGaD
Voriconazole—Pain—Triamcinolone—psoriasis	2.19e-05	0.000158	CcSEcCtD
Voriconazole—Loss of consciousness—Prednisone—psoriasis	2.18e-05	0.000157	CcSEcCtD
Voriconazole—Hypotension—Dexamethasone—psoriasis	2.17e-05	0.000157	CcSEcCtD
Voriconazole—Hypotension—Betamethasone—psoriasis	2.17e-05	0.000157	CcSEcCtD
Voriconazole—Pruritus—Cyclosporine—psoriasis	2.16e-05	0.000156	CcSEcCtD
Voriconazole—Urticaria—Hydrocortisone—psoriasis	2.16e-05	0.000156	CcSEcCtD
Voriconazole—Angiopathy—Methotrexate—psoriasis	2.16e-05	0.000156	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	2.15e-05	0.0015	CbGpPWpGaD
Voriconazole—Immune system disorder—Methotrexate—psoriasis	2.15e-05	0.000155	CcSEcCtD
Voriconazole—Abdominal pain—Hydrocortisone—psoriasis	2.15e-05	0.000155	CcSEcCtD
Voriconazole—Body temperature increased—Hydrocortisone—psoriasis	2.15e-05	0.000155	CcSEcCtD
Voriconazole—Convulsion—Prednisone—psoriasis	2.14e-05	0.000155	CcSEcCtD
Voriconazole—Mediastinal disorder—Methotrexate—psoriasis	2.14e-05	0.000155	CcSEcCtD
Voriconazole—Asthenia—Mycophenolate mofetil—psoriasis	2.14e-05	0.000154	CcSEcCtD
Voriconazole—Hypertension—Prednisone—psoriasis	2.14e-05	0.000154	CcSEcCtD
Voriconazole—FMO1—Metabolism—CAT—psoriasis	2.14e-05	0.00149	CbGpPWpGaD
Voriconazole—Chills—Methotrexate—psoriasis	2.13e-05	0.000154	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Betamethasone—psoriasis	2.11e-05	0.000153	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Dexamethasone—psoriasis	2.11e-05	0.000153	CcSEcCtD
Voriconazole—Pruritus—Mycophenolate mofetil—psoriasis	2.11e-05	0.000152	CcSEcCtD
Voriconazole—Myalgia—Prednisone—psoriasis	2.11e-05	0.000152	CcSEcCtD
Voriconazole—Arthralgia—Prednisone—psoriasis	2.11e-05	0.000152	CcSEcCtD
Voriconazole—Feeling abnormal—Triamcinolone—psoriasis	2.11e-05	0.000152	CcSEcCtD
Voriconazole—Anxiety—Prednisone—psoriasis	2.1e-05	0.000152	CcSEcCtD
Voriconazole—Alopecia—Methotrexate—psoriasis	2.1e-05	0.000152	CcSEcCtD
Voriconazole—Insomnia—Dexamethasone—psoriasis	2.1e-05	0.000152	CcSEcCtD
Voriconazole—Insomnia—Betamethasone—psoriasis	2.1e-05	0.000152	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.09e-05	0.000151	CcSEcCtD
Voriconazole—Diarrhoea—Cyclosporine—psoriasis	2.09e-05	0.000151	CcSEcCtD
Voriconazole—Paraesthesia—Betamethasone—psoriasis	2.08e-05	0.00015	CcSEcCtD
Voriconazole—Paraesthesia—Dexamethasone—psoriasis	2.08e-05	0.00015	CcSEcCtD
Voriconazole—Discomfort—Prednisone—psoriasis	2.08e-05	0.00015	CcSEcCtD
Voriconazole—Mental disorder—Methotrexate—psoriasis	2.08e-05	0.00015	CcSEcCtD
Voriconazole—Erythema—Methotrexate—psoriasis	2.07e-05	0.000149	CcSEcCtD
Voriconazole—Malnutrition—Methotrexate—psoriasis	2.07e-05	0.000149	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—CYP2S1—psoriasis	2.06e-05	0.00144	CbGpPWpGaD
Voriconazole—Hypersensitivity—Prednisolone—psoriasis	2.05e-05	0.000148	CcSEcCtD
Voriconazole—Dyspepsia—Betamethasone—psoriasis	2.04e-05	0.000147	CcSEcCtD
Voriconazole—Dyspepsia—Dexamethasone—psoriasis	2.04e-05	0.000147	CcSEcCtD
Voriconazole—Diarrhoea—Mycophenolate mofetil—psoriasis	2.04e-05	0.000147	CcSEcCtD
Voriconazole—Urticaria—Triamcinolone—psoriasis	2.03e-05	0.000147	CcSEcCtD
Voriconazole—Dysgeusia—Methotrexate—psoriasis	2.03e-05	0.000146	CcSEcCtD
Voriconazole—Body temperature increased—Triamcinolone—psoriasis	2.02e-05	0.000146	CcSEcCtD
Voriconazole—Dizziness—Cyclosporine—psoriasis	2.02e-05	0.000146	CcSEcCtD
Voriconazole—Oedema—Prednisone—psoriasis	2.02e-05	0.000146	CcSEcCtD
Voriconazole—Anaphylactic shock—Prednisone—psoriasis	2.02e-05	0.000146	CcSEcCtD
Voriconazole—Decreased appetite—Betamethasone—psoriasis	2.02e-05	0.000146	CcSEcCtD
Voriconazole—Decreased appetite—Dexamethasone—psoriasis	2.02e-05	0.000146	CcSEcCtD
Voriconazole—Infection—Prednisone—psoriasis	2.01e-05	0.000145	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Dexamethasone—psoriasis	2e-05	0.000145	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Betamethasone—psoriasis	2e-05	0.000145	CcSEcCtD
Voriconazole—Back pain—Methotrexate—psoriasis	2e-05	0.000144	CcSEcCtD
Voriconazole—Hypersensitivity—Hydrocortisone—psoriasis	2e-05	0.000144	CcSEcCtD
Voriconazole—PTGS1—Metabolism—CYP2S1—psoriasis	1.99e-05	0.00139	CbGpPWpGaD
Voriconazole—Shock—Prednisone—psoriasis	1.99e-05	0.000144	CcSEcCtD
Voriconazole—Pain—Dexamethasone—psoriasis	1.98e-05	0.000143	CcSEcCtD
Voriconazole—Pain—Betamethasone—psoriasis	1.98e-05	0.000143	CcSEcCtD
Voriconazole—Nervous system disorder—Prednisone—psoriasis	1.98e-05	0.000143	CcSEcCtD
Voriconazole—Tachycardia—Prednisone—psoriasis	1.97e-05	0.000142	CcSEcCtD
Voriconazole—Dizziness—Mycophenolate mofetil—psoriasis	1.97e-05	0.000142	CcSEcCtD
Voriconazole—Skin disorder—Prednisone—psoriasis	1.96e-05	0.000142	CcSEcCtD
Voriconazole—Hyperhidrosis—Prednisone—psoriasis	1.95e-05	0.000141	CcSEcCtD
Voriconazole—Vision blurred—Methotrexate—psoriasis	1.95e-05	0.000141	CcSEcCtD
Voriconazole—Asthenia—Hydrocortisone—psoriasis	1.95e-05	0.000141	CcSEcCtD
Voriconazole—Vomiting—Cyclosporine—psoriasis	1.94e-05	0.00014	CcSEcCtD
Voriconazole—Rash—Cyclosporine—psoriasis	1.93e-05	0.000139	CcSEcCtD
Voriconazole—Anorexia—Prednisone—psoriasis	1.93e-05	0.000139	CcSEcCtD
Voriconazole—Dermatitis—Cyclosporine—psoriasis	1.92e-05	0.000139	CcSEcCtD
Voriconazole—Pruritus—Hydrocortisone—psoriasis	1.92e-05	0.000139	CcSEcCtD
Voriconazole—Ill-defined disorder—Methotrexate—psoriasis	1.92e-05	0.000139	CcSEcCtD
Voriconazole—Headache—Cyclosporine—psoriasis	1.91e-05	0.000138	CcSEcCtD
Voriconazole—Anaemia—Methotrexate—psoriasis	1.91e-05	0.000138	CcSEcCtD
Voriconazole—Feeling abnormal—Dexamethasone—psoriasis	1.91e-05	0.000138	CcSEcCtD
Voriconazole—Feeling abnormal—Betamethasone—psoriasis	1.91e-05	0.000138	CcSEcCtD
Voriconazole—Gastrointestinal pain—Dexamethasone—psoriasis	1.9e-05	0.000137	CcSEcCtD
Voriconazole—Gastrointestinal pain—Betamethasone—psoriasis	1.9e-05	0.000137	CcSEcCtD
Voriconazole—Vomiting—Mycophenolate mofetil—psoriasis	1.89e-05	0.000137	CcSEcCtD
Voriconazole—Hypersensitivity—Triamcinolone—psoriasis	1.88e-05	0.000136	CcSEcCtD
Voriconazole—Rash—Mycophenolate mofetil—psoriasis	1.88e-05	0.000136	CcSEcCtD
Voriconazole—Dermatitis—Mycophenolate mofetil—psoriasis	1.88e-05	0.000136	CcSEcCtD
Voriconazole—Headache—Mycophenolate mofetil—psoriasis	1.87e-05	0.000135	CcSEcCtD
Voriconazole—Malaise—Methotrexate—psoriasis	1.87e-05	0.000135	CcSEcCtD
Voriconazole—Vertigo—Methotrexate—psoriasis	1.86e-05	0.000134	CcSEcCtD
Voriconazole—Diarrhoea—Hydrocortisone—psoriasis	1.86e-05	0.000134	CcSEcCtD
Voriconazole—Leukopenia—Methotrexate—psoriasis	1.85e-05	0.000134	CcSEcCtD
Voriconazole—Urticaria—Dexamethasone—psoriasis	1.84e-05	0.000133	CcSEcCtD
Voriconazole—Urticaria—Betamethasone—psoriasis	1.84e-05	0.000133	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Prednisone—psoriasis	1.84e-05	0.000133	CcSEcCtD
Voriconazole—Dizziness—Prednisolone—psoriasis	1.84e-05	0.000133	CcSEcCtD
Voriconazole—Asthenia—Triamcinolone—psoriasis	1.83e-05	0.000132	CcSEcCtD
Voriconazole—Abdominal pain—Dexamethasone—psoriasis	1.83e-05	0.000132	CcSEcCtD
Voriconazole—Body temperature increased—Betamethasone—psoriasis	1.83e-05	0.000132	CcSEcCtD
Voriconazole—Abdominal pain—Betamethasone—psoriasis	1.83e-05	0.000132	CcSEcCtD
Voriconazole—Body temperature increased—Dexamethasone—psoriasis	1.83e-05	0.000132	CcSEcCtD
Voriconazole—Insomnia—Prednisone—psoriasis	1.83e-05	0.000132	CcSEcCtD
Voriconazole—Nausea—Cyclosporine—psoriasis	1.81e-05	0.000131	CcSEcCtD
Voriconazole—Paraesthesia—Prednisone—psoriasis	1.81e-05	0.000131	CcSEcCtD
Voriconazole—Pruritus—Triamcinolone—psoriasis	1.81e-05	0.000131	CcSEcCtD
Voriconazole—Cough—Methotrexate—psoriasis	1.8e-05	0.00013	CcSEcCtD
Voriconazole—Dizziness—Hydrocortisone—psoriasis	1.8e-05	0.00013	CcSEcCtD
Voriconazole—Convulsion—Methotrexate—psoriasis	1.79e-05	0.000129	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—NDUFA5—psoriasis	1.79e-05	0.00125	CbGpPWpGaD
Voriconazole—Dyspepsia—Prednisone—psoriasis	1.78e-05	0.000128	CcSEcCtD
Voriconazole—Nausea—Mycophenolate mofetil—psoriasis	1.77e-05	0.000128	CcSEcCtD
Voriconazole—Myalgia—Methotrexate—psoriasis	1.76e-05	0.000127	CcSEcCtD
Voriconazole—Chest pain—Methotrexate—psoriasis	1.76e-05	0.000127	CcSEcCtD
Voriconazole—Arthralgia—Methotrexate—psoriasis	1.76e-05	0.000127	CcSEcCtD
Voriconazole—Decreased appetite—Prednisone—psoriasis	1.76e-05	0.000127	CcSEcCtD
Voriconazole—Rash—Prednisolone—psoriasis	1.75e-05	0.000127	CcSEcCtD
Voriconazole—Dermatitis—Prednisolone—psoriasis	1.75e-05	0.000126	CcSEcCtD
Voriconazole—CYP3A5—Metabolism—NDUFA5—psoriasis	1.75e-05	0.00122	CbGpPWpGaD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	1.75e-05	0.000126	CcSEcCtD
Voriconazole—Headache—Prednisolone—psoriasis	1.74e-05	0.000126	CcSEcCtD
Voriconazole—Discomfort—Methotrexate—psoriasis	1.74e-05	0.000126	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.74e-05	0.00121	CbGpPWpGaD
Voriconazole—Constipation—Prednisone—psoriasis	1.73e-05	0.000125	CcSEcCtD
Voriconazole—Vomiting—Hydrocortisone—psoriasis	1.73e-05	0.000125	CcSEcCtD
Voriconazole—Rash—Hydrocortisone—psoriasis	1.71e-05	0.000124	CcSEcCtD
Voriconazole—Dermatitis—Hydrocortisone—psoriasis	1.71e-05	0.000124	CcSEcCtD
Voriconazole—Confusional state—Methotrexate—psoriasis	1.7e-05	0.000123	CcSEcCtD
Voriconazole—Headache—Hydrocortisone—psoriasis	1.7e-05	0.000123	CcSEcCtD
Voriconazole—Dizziness—Triamcinolone—psoriasis	1.69e-05	0.000122	CcSEcCtD
Voriconazole—Anaphylactic shock—Methotrexate—psoriasis	1.69e-05	0.000122	CcSEcCtD
Voriconazole—Infection—Methotrexate—psoriasis	1.68e-05	0.000121	CcSEcCtD
Voriconazole—Feeling abnormal—Prednisone—psoriasis	1.66e-05	0.00012	CcSEcCtD
Voriconazole—Asthenia—Dexamethasone—psoriasis	1.66e-05	0.00012	CcSEcCtD
Voriconazole—Asthenia—Betamethasone—psoriasis	1.66e-05	0.00012	CcSEcCtD
Voriconazole—FMO1—Metabolism—APOE—psoriasis	1.66e-05	0.00116	CbGpPWpGaD
Voriconazole—Nervous system disorder—Methotrexate—psoriasis	1.66e-05	0.00012	CcSEcCtD
Voriconazole—Thrombocytopenia—Methotrexate—psoriasis	1.65e-05	0.000119	CcSEcCtD
Voriconazole—Gastrointestinal pain—Prednisone—psoriasis	1.65e-05	0.000119	CcSEcCtD
Voriconazole—Nausea—Prednisolone—psoriasis	1.65e-05	0.000119	CcSEcCtD
Voriconazole—Pruritus—Dexamethasone—psoriasis	1.64e-05	0.000119	CcSEcCtD
Voriconazole—Pruritus—Betamethasone—psoriasis	1.64e-05	0.000119	CcSEcCtD
Voriconazole—Skin disorder—Methotrexate—psoriasis	1.64e-05	0.000118	CcSEcCtD
Voriconazole—Hyperhidrosis—Methotrexate—psoriasis	1.63e-05	0.000118	CcSEcCtD
Voriconazole—Vomiting—Triamcinolone—psoriasis	1.63e-05	0.000117	CcSEcCtD
Voriconazole—Nausea—Hydrocortisone—psoriasis	1.61e-05	0.000116	CcSEcCtD
Voriconazole—Rash—Triamcinolone—psoriasis	1.61e-05	0.000116	CcSEcCtD
Voriconazole—Dermatitis—Triamcinolone—psoriasis	1.61e-05	0.000116	CcSEcCtD
Voriconazole—Anorexia—Methotrexate—psoriasis	1.61e-05	0.000116	CcSEcCtD
Voriconazole—Urticaria—Prednisone—psoriasis	1.6e-05	0.000116	CcSEcCtD
Voriconazole—Headache—Triamcinolone—psoriasis	1.6e-05	0.000116	CcSEcCtD
Voriconazole—Abdominal pain—Prednisone—psoriasis	1.6e-05	0.000115	CcSEcCtD
Voriconazole—Body temperature increased—Prednisone—psoriasis	1.6e-05	0.000115	CcSEcCtD
Voriconazole—Diarrhoea—Betamethasone—psoriasis	1.59e-05	0.000115	CcSEcCtD
Voriconazole—Diarrhoea—Dexamethasone—psoriasis	1.59e-05	0.000115	CcSEcCtD
Voriconazole—Hypotension—Methotrexate—psoriasis	1.58e-05	0.000114	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Methotrexate—psoriasis	1.54e-05	0.000111	CcSEcCtD
Voriconazole—Dizziness—Betamethasone—psoriasis	1.53e-05	0.000111	CcSEcCtD
Voriconazole—Dizziness—Dexamethasone—psoriasis	1.53e-05	0.000111	CcSEcCtD
Voriconazole—FMO3—Metabolism—CAT—psoriasis	1.53e-05	0.00107	CbGpPWpGaD
Voriconazole—Insomnia—Methotrexate—psoriasis	1.53e-05	0.00011	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—CYP2S1—psoriasis	1.52e-05	0.00106	CbGpPWpGaD
Voriconazole—Nausea—Triamcinolone—psoriasis	1.52e-05	0.00011	CcSEcCtD
Voriconazole—Paraesthesia—Methotrexate—psoriasis	1.52e-05	0.000109	CcSEcCtD
Voriconazole—Dyspnoea—Methotrexate—psoriasis	1.5e-05	0.000109	CcSEcCtD
Voriconazole—Somnolence—Methotrexate—psoriasis	1.5e-05	0.000108	CcSEcCtD
Voriconazole—Hypersensitivity—Prednisone—psoriasis	1.49e-05	0.000107	CcSEcCtD
Voriconazole—CYP3A5—Metabolism—CYP2S1—psoriasis	1.49e-05	0.00104	CbGpPWpGaD
Voriconazole—Dyspepsia—Methotrexate—psoriasis	1.49e-05	0.000107	CcSEcCtD
Voriconazole—Vomiting—Betamethasone—psoriasis	1.47e-05	0.000107	CcSEcCtD
Voriconazole—Vomiting—Dexamethasone—psoriasis	1.47e-05	0.000107	CcSEcCtD
Voriconazole—Decreased appetite—Methotrexate—psoriasis	1.47e-05	0.000106	CcSEcCtD
Voriconazole—Rash—Dexamethasone—psoriasis	1.46e-05	0.000106	CcSEcCtD
Voriconazole—Rash—Betamethasone—psoriasis	1.46e-05	0.000106	CcSEcCtD
Voriconazole—Dermatitis—Dexamethasone—psoriasis	1.46e-05	0.000106	CcSEcCtD
Voriconazole—Dermatitis—Betamethasone—psoriasis	1.46e-05	0.000106	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Methotrexate—psoriasis	1.46e-05	0.000105	CcSEcCtD
Voriconazole—Headache—Betamethasone—psoriasis	1.45e-05	0.000105	CcSEcCtD
Voriconazole—Headache—Dexamethasone—psoriasis	1.45e-05	0.000105	CcSEcCtD
Voriconazole—Asthenia—Prednisone—psoriasis	1.45e-05	0.000105	CcSEcCtD
Voriconazole—FMO1—Metabolism—PPARG—psoriasis	1.45e-05	0.00101	CbGpPWpGaD
Voriconazole—Pain—Methotrexate—psoriasis	1.44e-05	0.000104	CcSEcCtD
Voriconazole—Pruritus—Prednisone—psoriasis	1.43e-05	0.000103	CcSEcCtD
Voriconazole—Feeling abnormal—Methotrexate—psoriasis	1.39e-05	0.0001	CcSEcCtD
Voriconazole—Diarrhoea—Prednisone—psoriasis	1.38e-05	9.98e-05	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methotrexate—psoriasis	1.38e-05	9.97e-05	CcSEcCtD
Voriconazole—Nausea—Betamethasone—psoriasis	1.38e-05	9.95e-05	CcSEcCtD
Voriconazole—Nausea—Dexamethasone—psoriasis	1.38e-05	9.95e-05	CcSEcCtD
Voriconazole—CYP2C19—Metabolism—NDUFA5—psoriasis	1.35e-05	0.000944	CbGpPWpGaD
Voriconazole—Urticaria—Methotrexate—psoriasis	1.34e-05	9.69e-05	CcSEcCtD
Voriconazole—Dizziness—Prednisone—psoriasis	1.34e-05	9.65e-05	CcSEcCtD
Voriconazole—Abdominal pain—Methotrexate—psoriasis	1.33e-05	9.64e-05	CcSEcCtD
Voriconazole—Body temperature increased—Methotrexate—psoriasis	1.33e-05	9.64e-05	CcSEcCtD
Voriconazole—Vomiting—Prednisone—psoriasis	1.28e-05	9.28e-05	CcSEcCtD
Voriconazole—Rash—Prednisone—psoriasis	1.27e-05	9.2e-05	CcSEcCtD
Voriconazole—Dermatitis—Prednisone—psoriasis	1.27e-05	9.19e-05	CcSEcCtD
Voriconazole—Headache—Prednisone—psoriasis	1.27e-05	9.14e-05	CcSEcCtD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.26e-05	0.00088	CbGpPWpGaD
Voriconazole—Hypersensitivity—Methotrexate—psoriasis	1.24e-05	8.98e-05	CcSEcCtD
Voriconazole—CYP2C9—Metabolism—NDUFA5—psoriasis	1.23e-05	0.000861	CbGpPWpGaD
Voriconazole—Asthenia—Methotrexate—psoriasis	1.21e-05	8.75e-05	CcSEcCtD
Voriconazole—Nausea—Prednisone—psoriasis	1.2e-05	8.67e-05	CcSEcCtD
Voriconazole—Pruritus—Methotrexate—psoriasis	1.19e-05	8.63e-05	CcSEcCtD
Voriconazole—FMO3—Metabolism—APOE—psoriasis	1.19e-05	0.000828	CbGpPWpGaD
Voriconazole—Diarrhoea—Methotrexate—psoriasis	1.15e-05	8.34e-05	CcSEcCtD
Voriconazole—CYP2C19—Metabolism—CYP2S1—psoriasis	1.15e-05	0.000803	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.15e-05	0.000803	CbGpPWpGaD
Voriconazole—Dizziness—Methotrexate—psoriasis	1.12e-05	8.06e-05	CcSEcCtD
Voriconazole—Vomiting—Methotrexate—psoriasis	1.07e-05	7.75e-05	CcSEcCtD
Voriconazole—Rash—Methotrexate—psoriasis	1.06e-05	7.69e-05	CcSEcCtD
Voriconazole—Dermatitis—Methotrexate—psoriasis	1.06e-05	7.68e-05	CcSEcCtD
Voriconazole—Headache—Methotrexate—psoriasis	1.06e-05	7.64e-05	CcSEcCtD
Voriconazole—CYP2C9—Metabolism—CYP2S1—psoriasis	1.05e-05	0.000732	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-05	0.00073	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PPARG—psoriasis	1.03e-05	0.000722	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CARM1—psoriasis	1e-05	0.000702	CbGpPWpGaD
Voriconazole—Nausea—Methotrexate—psoriasis	1e-05	7.24e-05	CcSEcCtD
Voriconazole—PTGS1—Metabolism—CARM1—psoriasis	9.74e-06	0.00068	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.1e-06	0.000636	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NDUFA5—psoriasis	8.13e-06	0.000568	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CARM1—psoriasis	7.43e-06	0.000519	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CARM1—psoriasis	7.26e-06	0.000507	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP2S1—psoriasis	6.92e-06	0.000483	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CAT—psoriasis	6.18e-06	0.000432	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.03e-06	0.000421	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CAT—psoriasis	5.99e-06	0.000418	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CARM1—psoriasis	5.62e-06	0.000392	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.49e-06	0.000384	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.25e-06	0.000367	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CARM1—psoriasis	5.12e-06	0.000358	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—APOE—psoriasis	4.8e-06	0.000335	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.79e-06	0.000334	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—APOE—psoriasis	4.66e-06	0.000325	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CAT—psoriasis	4.57e-06	0.000319	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CAT—psoriasis	4.47e-06	0.000312	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PPARG—psoriasis	4.18e-06	0.000292	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PPARG—psoriasis	4.05e-06	0.000283	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—APOE—psoriasis	3.55e-06	0.000248	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—APOE—psoriasis	3.47e-06	0.000242	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CAT—psoriasis	3.45e-06	0.000241	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CARM1—psoriasis	3.38e-06	0.000236	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CAT—psoriasis	3.15e-06	0.00022	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PPARG—psoriasis	3.09e-06	0.000216	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PPARG—psoriasis	3.02e-06	0.000211	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—APOE—psoriasis	2.68e-06	0.000187	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—APOE—psoriasis	2.45e-06	0.000171	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PPARG—psoriasis	2.34e-06	0.000163	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PPARG—psoriasis	2.13e-06	0.000149	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CAT—psoriasis	2.08e-06	0.000145	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—APOE—psoriasis	1.61e-06	0.000113	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PPARG—psoriasis	1.41e-06	9.82e-05	CbGpPWpGaD
